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Antimicrobial resistance (AMR) is an acknowledged crisis for humanity. Its
genetic origins and dire potential outcomes are increasingly well understood.
However, diagnostic techniques for monitoring the crisis are currently largely
limited to enumerating the increasing incidence of resistant pathogens. Being
the end-stage of the evolutionary process that produces antimicrobial resistant
pathogens, these measurements, while diagnostic, are not prognostic, and so
are not optimal in managing this crisis. A better test is required. Here, using
insights from an understanding of evolutionary processes ruling the changing
abundance of genes under selective pressure, we suggest a predictive frame-
work for the AMR crisis. We then discuss the likely progression of resistance
for both existing and prospective antimicrobial therapies. Finally, we suggest
that by the environmental monitoring of resistance gene frequency, resistance
may be detected and tracked presumptively, and how this tool may be used to
guide decision-making in the local and global use of antimicrobials.1. Introduction
Antimicrobials in general and antibiotics specifically have had a large beneficial
impact on humanity by reducing or preventing infection, disease and epidemic,
and also through their improvement of food production and security. However,
the number of infectious diseases whose treatment is complicated or even pre-
cluded by the failure of existing antimicrobial therapies continues to increase
and is already a significant crisis for humanity [1–3]. Consequently, the prospect
of the failure of antimicrobials as a class and the resulting impact on humanity, par-
ticularly in view of our rapidly enlarging and increasingly connected population,
is dire [3].
It is widely accepted that the antimicrobial resistance (AMR) crisis has been
caused by the widespread and indiscriminate use of antimicrobials both clinically
and in the environment [4,5]. This intense usage has caused those characters that
confer resistance to antimicrobials in microorganisms to become both more
common and diverse in microbial communities globally. Resistance to antibiotics,
in particular, has increased globally since the widespread introduction of
penicillin during World War II. In this time, widespread resistance to not only
penicillin, but also its derivatives and all other available antibiotics, has become
evident.
To date, the management of this crisis, while multifactorial and widely
acknowledged as necessary, has failed to halt or even meaningfully decrease
the incidence of AMR in previously manageable diseases [1,2]. A great deal of
attention has been applied to the need for development of novel antimicrobials
and therapies, public and clinical education, as well as legislative reform [1,2].
Yet little focus has been given to the problem of rapidly and accurately monitor-
ing the root cause of the AMR crisis. In the clinical world, accurate and
presumptive diagnosis is a cornerstone of modern medicine. Being able to sensi-
tively monitor the progress of disease and its treatment enables swift, accurate
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increasing variety of resistant pathogens in clinical environ-
ments [2] only documents the last stage of the process
whereby resistance arises, proliferates, becomes associated
with a pathogenic organism and ultimately comes to the atten-
tion of humanity as a newly resistant disease. Clearly, a more
presumptive diagnostic methodology is required.
The individual genetic mechanisms whereby genetic
material is modified and mobilized are becoming well under-
stood [5,6]. It is known that DNA, often containing many
types of adaptive gene, including AMR, is routinely transferred
among diverse types of microbes [7]. So, organisms that are
initially sensitive to one or more antimicrobial can acquire exist-
ing AMR genes and so become resistant. Importantly, this
resistance may then be heritable. We now recognize also that
AMR phenotypes and the genes that cause them are distinct
from pathogenicity, and so evolve and are selected for separ-
ately. So, the development or acquisition of AMR is not
restricted to pathogenic organisms. Rather, AMR can be
acquired broadly in the microbial world and will proliferate
when even a low level of antimicrobial stress is applied. By
only measuring in clinical environments the incidence of patho-
genic organisms that have acquired resistance genes, the huge
environmental reservoir of resistance genes available to patho-
gens is not considered. By contrast, by directly monitoring the
entire genetic resistance resource available to microbes, better
estimates of the changing scope of the AMR problem can be
made. Accordingly, we recommend that the frequency of resist-
ance providing genes in both clinical and in non-clinical
environments be measured and their changing frequency ana-
lysed over time. This apparently difficult task is made
substantially simpler because AMR phenotypes are often pro-
vided by families of single genes such as the bla, aadA, aadB
and sul types of gene, as well as others, so making the detection
and subsequent quantification of this subset of resistance genes
in complex mixtures relatively simple [8]. Then, with appropri-
ate sampling strategies, both spatial and longitudinal data of
AMR gene frequency can be analysed in the light of our under-
standing of the evolutionary process, to track the historic
progress of resistance genes and then predict their rise and
fall in microbial communities.
While it is common to assume that evolution proceeds
over geological time, there are also numerous examples of
the rapid evolution and consequent rise of organisms con-
taining novel traits. Perhaps the most graphic of these is the
rapid and widespread advent of AMR itself. Humans, in
applying a wide range of antimicrobials in high doses over
many years, have caused a strong, widespread and persistent
selective pressure to be applied to the microbial world. This
selective pressure has resulted in a rapid evolutionary
response [9–12]. This response has seen the spread of resist-
ance genes previously sequestered in low numbers within
microbial communities, as well as the production of new
AMR-providing genes. These resistance genes, in providing
an advantage under antimicrobial stress, enable the survival
of their hosts, and so become more common and may even
become ubiquitous in the evolving microbial community.
The ability to produce novel genes demonstrates that the
microbial world is remarkably protean in producing new
ways of combatting or otherwise taking advantage of both
existing and even completely synthetic challenges [13,14].
Therefore, it is also likely that there will be no single or even
durable solution in the future by which microbial infectionsmay be controlled. Consequently, in the absence of such a ser-
endipitous solution to the AMR problem, the measurement
and subsequent management of the processes whereby AMR
arises offer the best hope for long-term control.
Existing environmental studies of the presence of AMR
genes show that resistance genes are widely distributed and
can even be found in environments that are not apparently sub-
ject to antimicrobial stress, albeit at low frequencies [12,15]. The
application of even low levels of antimicrobial in even such
relatively isolated environments can produce genetic changes
that ultimately select for resistance genes [16]. These studies
imply that in order for environmental reservoirs of resistance
genes to be reduced to or maintained at low levels, selective
pressures that conserve these particular genes must be largely
eliminated in those environments. To prevent pollution with
resistance genes, migration between highly and less selective
pressure environments should also be controlled. The complete
withdrawal of an antibiotic from an environment, particularly
in a clinical context, may appear to be a drastic and possi-
bly futile measure; however, evolutionary models of gene
reduction in the absence of selection show encouraging results
[17]. Similarly, in studies of the incidence of phenotypic resist-
ance in environments where the causative antibiotic was either
removed or no longer required due to intense vaccination
programmes, a significant reduction in the rate of phenotypic
resistance was seen in only a few years [18–20]. While not elu-
cidating the underlying gene frequencies, these results suggest
that effective measures exist which, when coupled with gene
frequency monitoring, can manage the AMR crisis.
In order to substantiate our recommendation, we now
consider the rise of AMR from an evolutionary perspective.2. Measuring evolution
The adaptive abilities of individual organisms arise from their
genetic constitution (genome) and its differential expression.
Therefore, changes in the genome of an individual can result
in changes in their adaptive abilities. These changes may
arise through the addition or creation of novel genetic material,
through the changing modulation of the expression of existing
genes or else through the removal of genetic material.
2.1. Adaptation through the addition of genetic
material to microbial genomes
New phenotypes can arise through the addition of new genetic
material. This addition may be as a result of mutation, whereby
new genes are created de novo from previously non-coding
DNA or else from modification of a copy of an existing func-
tional gene [21,22]. Additionally, mutation through acting
upon the regulatory areas of DNA associated with an existing
gene may alter its expression and so also provide an adaptive
phenotype through this change in regulation. An example
of this is the upregulation of membrane efflux pumps in
Mycobacterium tuberculosis, so enabling the organism to more
rapidly remove antibiotic from the cell [23]. The rate at which
mutation proceeds is generally thought to be very slow, with
estimates ranging from 1 DNA base pair change in 104 to 1
in 109 per generation. However, under duress, microbial cells
may facilitate mutation under a generalized SOS response,
increasing to many base pair changes per genome per gener-














Figure 1. Change in community gene frequency under selective pressure. The rate at which gene frequency rises within a microbial community is largely dependent
upon the strength of the selective pressure. Where a selective pressure significantly impairs the reproductive success of a large proportion of the community, gene
frequency rises rapidly even though overall community numbers may decrease (a). Conversely, where the impairment is less severe or else does not affect a large
proportion of the community, this leads to a lower rate of increase (b). This latter effect, where the proportion of the population affected by a stressor decreases
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gene into another involves many random base changes, it is
clear that in the absence of instances of hyper-mutation, the
production of novel genes may be both a long and serendipi-
tous process. While the average rate of mutation may be low,
continued strong selective pressure across a wide range of
environments means that even rare resistance providing
mutations will be widely available to be selected for. So, effec-
tively monitoring resistance genes will also always require
screening for such novel genes that can arise at any time.
Existing genetic material, but novel to the host cell, may
also be introduced by the various processes of horizontal
gene transfer (HGT) [24]. These processes transfer DNA and
whatever genes it may contain from one cell to another, largely
irrespective of their differing lineages. Horizontally transfer-
rable DNA includes a vast library of adaptive characteristics
distributed across all microbial communities and stored over
geological periods of time [10,11]. HGT has been shown to be
largely responsible for the acquisition by sensitive microbes
of single and multiple AMR-determining genes, and so is a
major contributor to the current AMR crisis [8,25]. It is
known that many of the individual processes contributing to
HGT are themselves responsive to environmental stress. For
example, the integrase gene that causes the excision or insertion
of mobile gene cassettes within integron structures is upregu-
lated under cellular stress, thus increasing the rate at which
gene-containing cassettes are mobilized [26,27]. Similarly, the
natural transformation process of many microbes, allowing
the uptake of DNA from the environment, is increased under
environmental stress [28]. However, while the overall rate of
HGT may increase under stress, even its basal rate continually
enables the distribution of novel phenotypes across the
microbial world.
The processes whereby new phenotypes are produced act at
variable rates. Both the HGT and mutational responses have
been shown to provide adaptive phenotypes to microbial strains
within hours of the onset of an intense stressor [29] (A. Robinson2016, personal communication). However, despite the ability of
microbial communities to produce a more rapid adaptive
response under duress, even under negligible stress such new
phenotypes are still produced within microbial communities
[16]. Therefore, the determining factor in predicting whether
these genes and their associated phenotypes become common
in the environment is the selective process rather than the rate
at which they are generated. Additionally, where an adaptive
gene comes to predominate within a microbial community, its
frequency in adjacent communities will increase through
microbial migration. Even distant environments will eventually
receive migratory genes by this process. This phenomenon is
graphically illustrated by the presence of AMR genes, particu-
larly those associated with promiscuous class 1 integrons
being found in environments not apparently under antimicro-
bial selective pressure, such as Scandinavian lake bottoms and
desert soils [10,11,30]. This further underscores the importance
of selection rather than the genetic origin of genes in determining
the abundance of AMR.
Once a new functional gene and its corresponding pheno-
type arises, selection by ambient conditions will determine its
frequency within a microbial community. In simple terms,
under a single strong selective pressure, an adaptive gene that
provides advantage to its host will increase in frequency
within the community over relatively few generations and
shortly thereafter may be ubiquitous. The rate at which the
gene frequency of a selected for gene increases over time,
while showing a characteristic shape when graphed (figure 1),
is nevertheless dependent upon many factors [31]. These factors
include the strength of the selective pressure, the fitness of the
population under pressure as well as the presence of other selec-
tive pressures acting within the environment. Additionally, the
maximum frequency attained by a gene within a community
will be influenced by competition with other genes supplying
similar resistance phenotypes and also the degree to which a
gene may be easily mobilized. Nevertheless, by knowing the









Figure 2. Change of community gene frequency due to HGT and particularly natural transformation and recombination. The processes of HGT are stochastic. So, in
the absence of selection to drive an increase in gene frequency the chance of an existing gene being excised from the host DNA and subsequently lost is the same as
the gene frequency across the contributing community. Accordingly, where a gene is common in the community (a) it will become more so. Similarly, where a gene
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of the community’s current location on the curve can be made.
Consequently, predictions can be made regarding the gene’s
ultimate frequency within the microbial community and also
how long that might take [32].2.2. Adaptation through genome reduction
While the addition of new genetic material is often responsible
for the provision of novel adaptive phenotypes, there are also
inevitable costs to this addition, so decreasing the fitness of
the host. These costs include the replicative and expression
burden imposed by the presence of new genes as well as the
possibility of pleiotropic/epistatic interference of imported
genes with existing biochemical pathways [33]. It must be
noted that in some cases the addition of adaptive genes can
also increase the fitness of an organism even where selective
pressure for the apparent phenotype provided by the gene is
absent [34]. In general, where genes and the phenotypes they
provide do not actively contribute to the fitness of their host
organism, they tend to be inactivated or lost.
A variety of processes contribute to genome reduction.
Perhaps the most pervasive is the accumulation of random
mutations combined with the observed bias towards base
pair deletions [35]. This process, when acting upon DNA
that is not continually selected for, will slowly modify and
erode the sequence, first causing genes to lose their function,
and culminating in their loss to the genome. So, with no other
processes at work, this slow erosion results in a decrease in
adaptive gene frequency within a population.
Where an organism or community, initially under selective
pressure, enters a largely benign environment, the advantage
conferred by adaptive genes is lost, and often results in the
rapid loss of large segments of DNA from individual organ-
isms. Recent work has shown losses of many kb in single
and multiple indels when virulence and resistance factors con-
tained on mobile genetic elements are lost through the
processes of HGT [36,37]. At a further extreme, organisms
entering a nutrient-poor or single-nutrient environment have
been seen to rapidly delete even core genetic mechanismsassociated with metabolism of alternate nutrients [37]. These
effects are most often seen in endosymbionts, where in later
stages not only nutritive genes but also those associated with
replication (as well as other core functions) are lost. Examples
of this process include the markedly diminished genome of
M. leprae when compared with its close relative M. tuberculosis
and many others [23].
Finally, the process of natural transformation has been
shown to be much more widespread and effective than
previously thought [28,38,39]. This process, whereby naked
DNA is taken up from the environment, enables the rapid
and frequent uptake of large (many kb) DNA fragments.
Where such DNA fragments themselves contain mobile DNA
such as transposons or gene cassettes, such elements may
then be integrated into the host DNA through mechanisms of
HGT such as transposition or site-specific recombination. How-
ever, where the introduced DNA does not include a mobile
element, homologous recombination alone may result in the
excision of a segment of host DNA containing a resident
mobile element so eliminating it from the genome and from
subsequent replication. The frequency with which such elimin-
ations of mobile elements occur is inversely proportional to the
frequency of such elements within the microbial community.
Thus, where a mobile element is rare within a community, in
the absence of selection to increase its frequency, it will be
rapidly lost. Similarly, where a mobile element is common or
even predominates within a community, the process of homolo-
gous recombination following transformation will serve to
maintain or even increase its frequency (figure 2).2.3. Spatial considerations
The foregoing discussion assumes that the community
undergoing selection is isolated from all other microbial
communities. In practice, migration between microbial com-
munities must also be considered in modelling the ultimate
evolutionary fate of genes [40,41].
Where selection occurs in a single location, as would be
the case in a hospital utilizing a novel antimicrobial, selection










Figure 3. A hypothetical example of the changing geographical distribution of resistance genes. The changing spatial distribution of resistance genes can be used as
an indicative measure of gene migration and hence the effectiveness of both stewardship and control programmes. Additionally, the availability of areas of low gene
frequencies adjacent to areas of intense antimicrobial usage (a) may offer the ability to ‘dilute’ areas of high resistance gene frequency and so hasten the removal of
resistance genes from the community. By applying geographical information system (GIS) or network analysis approaches to such information, correlations with














Figure 4. The overall change in community gene frequency with time. When the mechanisms that compete to change gene frequency within a community are
considered together, it is clear that in order to rapidly reduce gene frequency (a), a low starting frequency (b) in the absence of selection is required. One way this
may be achieved is to apply only a weak selective pressure (b) to the environment. Alternatively, early intervention to remove high selective pressures before a high
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With the introduction of organisms from outside the hospital
environment not containing resistance genes, the overall rise
of resistance gene frequency within the hospital is delayed as
the resistance gene is diluted within the hospital’s microbial
community. Conversely, the migration of resistance-gene-
carrying organisms from the selective hospital environment
to the surrounding non-selective environment creates a
wider reservoir of selective genes that may be reintroduced
into the hospital environment after selection there has
ceased, so delaying the reduction of resistance gene fre-
quency within the hospital. This effect would become more
pronounced if a selective pressure, even at a low level, was
applied to the environment surrounding the hospital, thusdelaying or preventing the resistance genes from being
eliminated there (figure 3).
2.4. Summation
When considered as a complete process (figure 4), that is, a
community undergoing selection followed by the withdrawal
of selection, it is clear that the ultimate fate of an adaptive
gene under selection within the community is dependent
on the strength of the selective pressure applied and the dur-
ation for which it is applied. A strong selective pressure
applied for long periods of time will increase the gene
frequency of an adaptive gene to the point where its removal
from the community metagenome after the removal of the
rsob.royalsocietypublishing.org
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 on June 27, 2017http://rsob.royalsocietypublishing.org/Downloaded from stressor will take many generations, if it happens at all. Con-
versely, where a selective pressure is applied weakly, locally
and for short durations, the frequency of adaptive genes will
not rise to high levels. Therefore, upon the removal of the
stressor upon such communities, the frequency of such
genes would be rapidly decreased in the metagenome.
Consequently, this information when applied to resistance
genes, with knowledge of the history of resistance gene fre-
quency within an environment, provides both diagnostic
and prognostic information that can guide the subsequent
application of environmental stressors such as antimicrobials.Open
Biol.6:1602363. Implementation
We recommend that, in conjunction with the use of antimicro-
bials, a programme for monitoring the complementary
resistance gene frequencies in environments within and
surrounding the antimicrobial usage sites should be
implemented.
3.1. Sampling
Sampling the environmental metagenome requires that sampling
be both reproducible and repeatable over the life of the exper-
iment. This is especially important in an ongoing programme
of monitoring resistance gene frequencies in environments
including human society. The principal interest of such a diag-
nostic study is to monitor resistance genes with a particular
interest in both their presence and availability to potential
human pathogens. Thus, appropriate sampling techniques
necessarily invoke a bias towards sampling the microbial
metagenome in close proximity to large numbers of humans.
It is current practice in many hospitals to sample the
clinical environment for the presence of resistant pathogens.
Most often, sampling consists of surface swabs and air samples
taken from locations within the hospital. These samples are
variously collected onto swabs or membrane filters that are
subsequently cultured in selective media to identify both
pathogens and their resistance profiles. We recommend that
this procedure continue so as to identify newly arisen resist-
ance genes not currently screened for. In addition to these
culturable samples, we recommend that parallel swab and
filter samples for direct metagenomic DNA extraction be
taken. Direct extraction of DNA samples without intervening
culture will capture the DNA of both cultural and unculturable
microorganisms in the environment and retain the relative
abundances of both organisms and the genes they contain [42].
In addition to clinical environments that are presumed to
be a focus of resistance gene prevalence, comparative sampling
of surrounding environments frequented by humans but not
exposed to high antimicrobial usage should also be under-
taken. Taking surface swabs and air samples both for culture
and DNA analysis in the undercover areas of shopping pre-
cincts or transport hubs at increasing ranges from the clinical
environment would be appropriate.
While necessarily only accessing that fraction of the micro-
biome that survives transit through the human gut, samples
taken from sewerage may be a useful adjunct. Such samples
taken from sewerage mains draining urban and clinical environ-
ments may be more reproducible and less obtrusive to the
general public, and so may offer an alternate means of
implementing a gene frequency monitoring programme.3.2. Sampling frequencies
Because quantitative results are required from the proposed
work, it is necessary to quantify the variability inherent in the
sampling and analysis techniques. So, environmental samples
should always be collected in replicates. Periodically, replicate
studies of each stage of the analytical process should be
undertaken to establish the reproducibility of the methods
used. Quantitative studies of metagenomic DNA have shown
that less than a 10% Standard Error is routinely achievable,
with the PCR step being the most variable portion of the
analytical routine [43].
Once the variability inherent in the methodology is
known, the sampling period may be set when the difference
in sample values taken at subsequent times exceeds the
methodological variation.
3.3. Measuring gene frequency
A wide variety of existing molecular techniques have been
demonstrated to recover and analyse environmental meta-
genomic DNA [15,16,44]. These techniques include next-
generation sequencing as well as chip-based methodologies,
though perhaps the simplest and most cost-effective methods
use quantitative PCR (QPCR). Using established techniques to
gather environmental DNA, resistance gene frequency may be
simply established by the ratio of the QPCR value of the resist-
ance gene or gene family, relative to generally conserved genes
such as 16s rRNA or rpoB [30,45,46]. Because resistance genes
are subject to selection they are often seen to diversify into
gene families such as the hundred or more different bla genes.
These gene families can be usefully measured with a limited
number of QPCRs through the use of either degenerate or
consensus PCR primers. Genes providing AMR phenotypes
not provided by known genes can be defined through
continued phenotypic testing and subsequent DNA sequencing.
Where resistance genes are known to be less mobile, as in the
case of mutated genes or upregulated biochemical pathways,
rather than measuring the total microbiome, a strain-specifically
conserved reference gene may be utilized instead of rpoB.
The gene frequency information gathered longitudinally in
the real world is unlikely to produce the smooth curves seen in
the figures shown. Rather, sources of variability including vari-
ations in experimental technique, environmental changes as
well as the influence of specific events such as epidemics or
the introduction of vaccines will necessarily affect the results.
Yet measuring and then accounting for such variability is
already common in a variety of routine pathological method-
ologies and quality control programmes [47]. Consequently,
measuring gene frequencies and then accounting for variabil-
ity will allow overarching trends in resistance gene frequency
to become evident.
3.4. Geopolitical considerations
It is perhaps beyond the purview of this work to suggest geo-
political structures whereby the AMR crisis can be managed.
We note, however, that regional initiatives can produce short-
term results beneficial to the local communities. The literature
demonstrates that the frequency of resistance genes in a region
can decrease markedly upon the withdrawal of selective
pressure [17–19]. However, the AMR crisis is a global
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Rather, the ecology of the planet is interconnected, and the
increasingly large and mobile human population only facili-
tates this interconnection. Accordingly, the AMR crisis
requires a global perspective in effectively managing it.
In human terms, the world is sub-divided into many distinct
administrative units such as states and countries, each of suitable
size for the implementation of initiatives to regionally manage
AMR. However, the global nature of the problem suggests that
global coordination of management initiatives is also required.
There exist a number peak health bodies, such as the World
Health Organization, the Centers for Disease Control and Preven-
tion, and others, currently concerned by the AMR crisis whose
advisory roles to country governments and global perspective
would be appropriate in facilitating the implementation of the
additional measures we suggest here. Further, it is hoped that
our academic colleagues will also commence projects to locally
longitudinally measure the changing frequency of resistance
genes and in doing so refine the techniques involved and also
offer insights into issues in the management of the crisis.
We see that such efforts will form the basis of a broad-based
and rigorous AMR management programme into the future.4. Stewardship of existing antimicrobials
4.1. Monitoring the frequency of currently prevalent
resistance genes
Trends in resistance gene frequency over time indicate a
number of factors that are relevant to the management of
AMR. By considering the rise or fall of gene frequency and at
what rate, an estimate of the future prevalence of that gene
can be made. For example, a low frequency of a particular
resistance gene with an exponentially increasing trend
indicates a strong current selective pressure for that gene. Simi-
larly, a high-frequency gene without an increasing trend could
indicate saturation of the environment with that gene.
By including other indicators, additional trends can
be established. By continued monitoring of phenotypic resist-
ance, as is already done in enumerating resistant pathogens,
useful additional information is provided. For example, where
increasing phenotypic resistance is seen despite a decreasing fre-
quency of the monitored resistance gene, it could indicate
the presence and increasing abundance of a novel resistance
gene in the community. Further, an increase in resistance gene
frequency without a corresponding rise in the incidence of resist-
ant pathogens suggests a proliferation of the gene outside
pathogenic hosts as the diversity and abundance of the genetic
contexts for the resistance gene increase in the environment.
While not of immediate concern clinically, this increased abun-
dance of resistance genes in the metagenomic pool available to
sensitive pathogens is of distinct concern in the ongoing
management of AMR.
By including spatial variations in gene frequency measure-
ments even more information would be gained. For example,
a high resistance gene frequency localized to a clinical
setting would indicate the effectiveness of containment
measures, and would also suggest that the removal of selective
pressure might produce a rapid dilution of resistance gene
frequency through inward migration from surrounding com-
munities. Conversely, slowly increasing gene frequencies in
non-clinical environments could indicate that managementmeasures were not entirely effective and, perhaps more impor-
tantly, that the reservoir of non-resistant strains in the larger
environment was decreasing.
The stewardship of existing antimicrobials requires two
broad areas of consideration in order both to ensure current
utility and also to maintain long-term efficacy. These are
the minimization of overall antimicrobial usage and the
isolation of necessary antimicrobial usage from the wider
microbial environment.
The first of these considerations requires that antimicro-
bials be administered in the lowest possible dose and for
the shortest possible time required in order to achieve the
desired clinical result. While lowered antimicrobial usage
already forms part of the global strategy for managing
AMR, by monitoring gene frequencies as a result of the use
of antimicrobials, levels of usage that take into account
AMR can be established. For example, where resistance
genes specific to one type of antimicrobial are notably more
frequent than genes against other antimicrobials, recommen-
dations can be made that, where clinically appropriate, these
alternative antimicrobials should be used preferentially.
The second consideration ideally requires that, particularly
in a clinical context, an antimicrobial’s metabolic breakdown
products, as well as the microbial community exposed to its
use, should be isolated from the wider microbial community.
This means that resistance genes and the stressors that facilitate
them will all be isolated from the general environment, thus
reducing the opportunity for widespread dissemination of
any resistance genes present. While apparently draconian in
concept, the implementation of such measures is only slightly
more complex than the currently accepted clinical techniques
of isolation/quarantine wards and barrier nursing. The
addition of PC2 laboratory-type precautions combined with
measures to sterilize all effluvium from such facilities should
prove effective in limiting both resistance gene and antimicro-
bial stressor flow to the environment. In the implementation
of new antimicrobials and therapies where resistance gene
frequency is low, such measures will ensure that treatment
remains effective and hence rapid while preserving the
long-term utility of the antimicrobial.
4.2. Stewardship of novel antimicrobials
An important strategy in managing the AMR crisis is the search
for and development of new antimicrobial agents as well as
better diagnostics and therapies [48–50]. Our existing antimicro-
bial repertoire has its origins in the microbial world, where these
materials have been used in the long-term competition among
differing types of microbe, and so it would seem likely that
new antimicrobials might be found in the same arena. Similarly,
resistance genes themselves have their origins deep within
microbial contention [25]. So, it is likely that any new antimicro-
bial found will also have a suite of complementary resistance
phenotypes already resident in the environment at some low fre-
quency. In the implementation of new antimicrobials for the
improvement human health, genes contributing to these resist-
ance phenotypes should be identified before there is any
widespread utilization of the new antimicrobial. The frequency
of these resistance genes should subsequently be monitored
both where the antimicrobial is given and in the surrounding
environment, with any increase being seen as cause to consider
withdrawing the antimicrobial or reducing its use until the cor-
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frequency at which selective pressure is removed, the faster will
a microbial community reduce or eliminate such genes.
Consequently, in husbanding the long-term effectiveness of
new antimicrobials, identifying resistance genes and
then subsequently monitoring their frequency will enable
objective decisions to be made in the use of these therapeutic
materials for both the short-term benefit of patients as well as
the long-term stewardship of the antimicrobial.
Of course, it is likely that novel forms of resistance will
also become evident over time. Therefore, just as the presence
of existing resistance genes were to be determined during the
development of novel antimicrobials, continual surveillance
for new resistance genes, as is currently the practice, will
still be required. :1602365. Limitations
The suggested protocols discussed in this work are intended as
an effective diagnostic technique for measuring the changing
frequency of resistance genes in order to make decisions on
the ongoing use of antimicrobials. It should be noted that diag-
nostic techniques are intended to measure a key parameter
indicative of a disease to provide information for the timely
management of that disease. This is distinct in both application
and intent from research techniques that seek to elucidate the
disease and all of its causes. We acknowledge that micro-
bial ecology is a complex and as yet not completely defined
discipline, and that many factors and processes (such as organis-
mal stratification, genetic linkage of AMR genes and the
changing rate of HGT) within microbial communities exist
that may either enhance or impede the rate at which AMR
genes either proliferate or decline. We also acknowledge that
as a diagnostic technique, the measurement of AMR gene fre-
quencies is not intended to elucidate these individual effects.
Rather, the measurement of the changing incidence of AMR
genes will demonstrate the result of the sum of these effects
upon the microbial community and so will remain a useful diag-
nostic of the environmental AMR gene resource either present in
or available to pathogens.
Nevertheless, the scientific resource represented by the
stored metagenomic DNA samples collected initially for its
diagnostic value may well be able to elucidate many research
questions through the use of supplementary techniques such
as targeted PCR or bulk sequencing. Consequently, while the
initial intent of our proposed technique is diagnostic in nature,
the potential for concurrent pure research is not neglected.6. Discussion
By observing the gain or loss of adaptive genes from microbial
communities over time, trends will become evident and
estimates of the ultimate fate of such genes may be made. In
considering genes conferring resistance to antimicrobials cur-
rently in use, it may well be that many resistance genes have
already reached a high frequency in local and global commu-
nities, and so their decrease and subsequent loss from these
environments is unlikely. However, as yet, work estimating
the gene frequency of resistance genes across environments
as well as longitudinally has not been done, and so the predic-
tion of such a grim outcome is by no means certain. Indeed, the
fact that sensitivity to even the oldest of the routinely usedantibiotics (penicillin) remains detectable in clinical pathogens
suggests that the frequency of resistance-causing genes is
currently below saturation in the environments examined
(data not shown). Similarly, while multiply and even comple-
tely resistant pathogens are being detected globally, they also
remain relatively rare in most environments (data not
shown). These gross observations suggest that the AMR crisis
in the sampled environments has not yet reached an irrecover-
able state. Nevertheless, by making measurements of resistance
gene frequency directly, it will be possible to determine if these
empirical observations in fact reflect an increasing, static or
decreasing trend in the distribution and abundance of resist-
ance genes. By measuring how these parameters vary over
geographical distances across areas where the application of
antimicrobials is occurring, an accurate view of the state of
the evolutionary process will be gained, and this in turn will
suggest measures to manage it and will also offer a means to
judge the efficacy of these measures.
As an indicatorof the utilityof monitoring gene frequencies, it
is useful to note that some studies have been completed which
measure the abundance of either resistance genes or their DNA
mobilizing hosts at a single point in time [15,30]. These studies
have illustrated the presence of resistance genes in environments
not directly associated with intense antimicrobial usage and the
proclivity of these environments to select for these genes even
under very low levels of applied antimicrobial stressors [15].
This information, while not indicating future trends, is neverthe-
less useful in demonstrating that resistance genes are widely
spread, even though these studies do not elucidate whether
their presence is due to recent arrival or else that they are ubiqui-
tous and present at a low level in many environments. This work
also shows that molecular methods to assess genetic constitution
of environmental metagenomes is not only practical, but also sen-
sitive and specific. Consequently, the routine longitudinal
measurement of antibiotic resistance gene frequencies from
environmental samples can easily become a regular feature in
the management of the AMR crisis.7. Conclusion
An uncontained AMR crisis promises an increased incidence and
a wider variety of infectious diseases across the entire human
population. Additionally, many medical and quasi-medical pro-
cedures, currently blithely undertaken, will incur increasing risk
of infection and death. Less obvious consequences include threats
to food security and increasing ramifications for the individual
human microbiota, as well as the wider ecology. From this per-
spective, efforts to monitor, ameliorate and perhaps manage the
AMR crisis, currently and into the foreseeable future become a
reasonable endeavour. Consequently, our suggestions here of
implementing techniques for monitoring resistance gene
frequency, and hence managing the AMR crisis, rather than
being an onerous imposition on the resources of the global
community, become a necessary adjunct to human society.
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